Table 1. Key features of the proposed scenarios for global elimination and eradication of LF.
Global Elimination (comparator) | Eradication I | Eradication II | Eradication III | |
---|---|---|---|---|
Intervention | MDA | MDA | MDA | MDA |
Coverage rate | 85% | 85% | 85% | 85% |
Countries considered | All LF endemic countries that have previously conducted MDA ¥ | All LF endemic countries ¥ , including all countries co-endemic with L. loa | All LF endemic countries ¥ , including all countries co-endemic with L. loa | All LF endemic countries ¥ , including all countries co-endemic with L. loa |
Rate of scale-up | Countries with previous MDA continue at same rate as historically | Countries with previous MDA continue at same historical rate, countries without previous progress begin at an ‘average’ rate of MDA scale-up (schedule II) | Schedule I: All countries add 20% of their at-risk populations to the MDA schedule annually | All countries treat 100% of their at-risk populations annually |
¥Assuming country requires MDA